Latest News and Press Releases
Want to stay updated on the latest news?
-
iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024
-
Zio ECG monitoring system is the only fourteen-day cardiac monitoring service in its category to receive Japanese regulatory approval as an improved device without a clinical trialZio ECG monitoring...
-
New data shows iRhythm’s next-generation Zio monitor LTCM patch ECG device superior real-world performance compared to prior generation device.
-
SAN FRANCISCO, Sept. 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and...
-
GUARD-AF trial results presented at European Society of Cardiology (ESC) Congress 2024
-
Il servizio di monitoraggio continuo a lungo termine (LTCM) Zio consiste in un dispositivo di monitoraggio ECG con cerotto esclusivamente su prescrizione (Zio® monitor) da indossare per un massimo di...
-
Zio long-term continuous monitoring (LTCM) service consists of a prescription only patch ECG monitoring device (Zio monitor) worn for up to 14 days, the ZEUS (Zio ECG Utilization Software) System...
-
De Zio-service voor langdurige doorlopende monitoring (LTCM) bestaat uit een ECG-monitor (Zio®-monitor) die op voorschrift gedurende maximaal 14 dagen kan worden gedragen, het ZEUS-systeem (Zio ECG...
-
Zio long-term continuous monitoring (LTCM) service consists of a prescription only patch ECG monitoring device (Zio monitor) worn for up to 14 days, the ZEUS (Zio ECG Utilization Software) System...
-
Zio long-term continuous monitoring (LTCM) service consists of a prescription only patch ECG monitoring device (Zio® monitor) worn for up to 14 days, the ZEUS (Zio ECG Utilization Software) System...